Hansen Medical to Showcase New Magellan(TM) 6Fr Robotic Catheter at 27th Annual ISET Meeting

MOUNTAIN VIEW, CA--(Marketwired - Jan 20, 2015) -  Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan™ Robotic System at the 27^th Annual International Symposium on Endovascular Therapy (ISET) January 31-February 4 at the Diplomat Hotel in Hollywood, FL. The Company will showcase the new Magellan 6Fr Robotic Catheter and will conduct Magellan Robotic System demonstrations at exhibit booth #305.

During this year's ISET meeting, Hansen Medical anticipates that the Magellan Robotic System will be featured in three scheduled physician presentations and in one live endovascular case, scheduled to be performed by Barry Katzen, MD, Founder and Medical Director of Miami Cardiac and Vascular Institute. The new 6Fr Robotic Catheter will also be highlighted in the event's "New Product Showcase".

The following sessions during ISET will include discussion about intravascular robotics:

January 31, Session V: Cool Tools and Robotics for Endovascular Suites, 1:15-1:30pm

• Fusion Technology and Robotic-Assisted Cases in IR - Constantino S. Peña, MD (Miami Cardiac & Vascular Institute, Miami, FL)

February 2, Session I: Advances in Carotid Stenting, 5:24-5:33pm

• What is the Potential Role for Robotics in Carotid Intervention? - Barry T. Katzen, MD (Miami Cardiac & Vascular Institute, Miami, FL)

February 2, Live Case, 1:00pm

• Barry T. Katzen, MD, Live From Baptist Hospital of Miami, Miami, FL

February 3, Session V: Hot Topics in Embolization Therapy, 4:30-4:40pm

• Robotically Guided Fibroid Embolization - Mohamad Hamady, MD (Imperial College, London, UK)

"We are excited to share the latest clinical experiences with our new Magellan 6Fr Robotic Catheter at the ISET meeting, which celebrates its 27^th year of bringing together a multi-disciplinary group of interventionalists to focus on acquiring the latest information about interventional medicine and the treatment of vascular disease," said Cary Vance, Hansen Medical's President and Chief Executive Officer. "The 6Fr Catheter has helped to expand the clinical applications for Magellan by enabling physicians and patients to benefit from robotic precision, control and stability during procedures in smaller blood vessels, including those accessed during peripheral embolization procedures."